| Chapter 4 - Biotechnology |
text |
produced high levels of human protein α1-antitrypsin in h... |
36 |
|
Delete Content |
| Chapter 4 - Biotechnology |
image |
/default_org/ncert_images/class-xii/b... |
37 |
|
Delete Content |
| Chapter 4 - Biotechnology |
text |
humans. Concerns arise over the use of viral vectors and ... |
38 |
|
Delete Content |
| Chapter 4 - Biotechnology |
image |
/default_org/ncert_images/class-xii/b... |
39 |
|
Delete Content |
| Chapter 4 - Biotechnology |
text |
as ‘Gene therapy’. Gene therapy is a technique designed t... |
40 |
|
Delete Content |
| Chapter 4 - Biotechnology |
image |
/default_org/ncert_images/class-xii/b... |
41 |
|
Delete Content |
| Chapter 4 - Biotechnology |
text |
Replacement of the defective form of p53 in cancer cells ... |
42 |
|
Delete Content |
| Chapter 4 - Biotechnology |
image |
/default_org/ncert_images/class-xii/b... |
43 |
|
Delete Content |
| Chapter 4 - Biotechnology |
text |
ex vivo gene therapy in vivo gene therapy Remove small po... |
44 |
|
Delete Content |
| Chapter 4 - Biotechnology |
image |
/default_org/ncert_images/class-xii/b... |
45 |
|
Delete Content |
| Chapter 4 - Biotechnology |
text |
• Gene inhibition therapy: Using antisense RNA or other i... |
46 |
|
Delete Content |
| Chapter 4 - Biotechnology |
image |
/default_org/ncert_images/class-xii/b... |
47 |
|
Delete Content |
| Chapter 4 - Biotechnology |
text |
4.3.4 Ethical Issues Bioethics refers to the assessment o... |
48 |
|
Delete Content |
| Chapter 4 - Biotechnology |
image |
/default_org/ncert_images/class-xii/b... |
49 |
|
Delete Content |
| Chapter 7 - Human Ecology a... |
text |
4b. Mention difficulties, if any, faced while organising/... |
72 |
|
Delete Content |
| Chapter 4 - Biotechnology |
text |
to the same pathogen, a quick and enhanced immune respons... |
50 |
|
Delete Content |
| Chapter 4 - Biotechnology |
image |
/default_org/ncert_images/class-xii/b... |
51 |
|
Delete Content |
| Chapter 4 - Biotechnology |
text |
Vaccinia virus A portion of genome Hepatitis B virus gene... |
52 |
|
Delete Content |
| Chapter 4 - Biotechnology |
image |
/default_org/ncert_images/class-xii/b... |
53 |
|
Delete Content |
| Chapter 4 - Biotechnology |
text |
protection against several different diseases. Such vacci... |
54 |
|
Delete Content |
| Chapter 4 - Biotechnology |
image |
/default_org/ncert_images/class-xii/b... |
55 |
|
Delete Content |
| Chapter 4 - Biotechnology |
text |
2. Recombinant subunit vaccines Subunit vaccines contain ... |
56 |
|
Delete Content |
| Chapter 4 - Biotechnology |
image |
/default_org/ncert_images/class-xii/b... |
57 |
|
Delete Content |
| Chapter 4 - Biotechnology |
text |
Box 5 The HBsAg gene is cleaved and ligated to a strong a... |
58 |
|
Delete Content |
| Chapter 4 - Biotechnology |
image |
/default_org/ncert_images/class-xii/b... |
59 |
|
Delete Content |